Established in 1975 as a member of Nevzat Group, Drogsan Pharmaceuticals is among Türkiye's leading pharmaceutical companies, specialized in development, manufacturing, registration, marketing, export, sales and distribution of pharmaceuticals and serving to the healthcare environment for 50 years under the motto of “Respect to Health”.

Driven by its strategic focus on being a research based, value added international pharmaceutical company, Drogsan is dedicated to provide healthcare professionals with innovative quality solutions and contribute to a healthier future. With its R&D functions focusing on value-added products, combinations and innovative dosage forms which would bring extra advantage to the treatment, Drogsan continuously develops its portfolio in various therapeutic areas with the goal of keeping pace with the dynamism of global pharmaceutical industry.

Ensuring continuous compliance to cGMP regulations, Drogsan is an ISO 9001:2015 certified manufacturer with a production facility and quality system approved by various health authorities globally, as well as pharmaceutical companies for which it provides contract manufacturing services. Drogsan’s manufacturing site consists of four production lines with capability to manufacture pharmaceuticals in tablet, hard capsule, soft gel capsule, sachet, syrup, suspension, solution and spray dosage forms.

On a corporate level, Drogsan is proud to be a brand of TURQUALITY program, supported by Turkish Ministry of Trade aiming to increase the competitiveness of Turkish brands in international markets by enhancing their managerial capacity, institutionalization and development. Having initiated a comprehensive corporate sustainability project, Drogsan is also taking great steps towards sustainable corporate development and contribution to the United Nations Sustainable Development Goals (SDGs).

With the vision of becoming a pharmaceutical company that is admired, permanent and followed in the domestic and international markets, Drogsan conducts distribution, marketing and sales activities through its partners in more than 30 countries including Southern Europe, Middle East, Central & Southeast Asia, Africa, and CIS countries with more than 200 international product licenses. Product registration activities also continue in other important pharmaceutical markets such as Eastern Europe, Gulf Region and Central America.

With its mission of being a growing global player in the world pharmaceutical industry, Drogsan continually adds new territories to its geographical coverage and seeks for markets with high potential to contribute to its expansion.